Software as a Medical Device (SaMD) Market By Deployment Type (Cloud Based, On Premise) , By Application (Screening and Diagnosis, Monitoring and Alerting, Chronic Disease Management, Digital Therapeutics, Others) By End User (Hospitals and Clinics, Home Care Settings, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
(SaMD) Software as a Medical Device Market
The (SaMD) software as a medical device market was valued at $19.5 million in 2023 and is projected to reach $96.2 million by 2033, growing at a CAGR of 17.3% from 2024 to 2033.
Software as a medical device (SaMD) is dedicated software designed for medical use through which functions are performed without the requirement of a hardware medical device. SaMD aids in managing patient health data, diagnosing health conditions, and recommending treatments. The software is highly versatile and accessible as it is easily accessible on general-purpose computing platforms such as smartphones and tablets. A key characteristic of SaMD is its potential to independently accomplish medical objectives, thereby accelerating the scope and efficiency of modern healthcare systems.
Increase in the adoption of telehealth and remote patient monitoring is a major driver of the (SaMD) software as a medical device market. In addition, support from several regulatory bodies such as the Food and Drug Administration and the European Union is boosting the demand for SaMD. To improve the healthcare providers’ assistance, the incorporation of Clinical Decision Support Systems (CDSS) is an emerging trend in the market. The capabilities of CDSS help in making evidence-based clinical decisions, thereby enhancing diagnostic accuracy and optimizing treatment procedures.
However, the integration of existing medical records and healthcare data into SaMD is a time-consuming and costly process, hence hampering the development of the (SaMD) software as a medical device market. Furthermore, usage of the software is subject to rigorous regulatory compliance by the U.S. Food and Drug Administration (FDA), which presents significant challenges for the SaMD developers. The regulatory requirements of FDA include premarket approval, strict quality check, post-market surveillance, cybersecurity requirements, and specific software modifications & updates. All these requirements ensure the reliability and efficacy of SaMD, thus preventing compromise with critical health data and patient records.
Segment Review
The (SaMD) software as a medical device market is segmented into deployment type, application, end user, and region. On the basis of deployment type, the market is bifurcated into cloud based and on premise. Depending on application, it is divided into screening & diagnosis, monitoring & alerting, chronic disease management, digital therapeutics, and others. As per end user, it is classified into hospitals & clinics, home care settings, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of deployment type, the cloud-based segment dominates the (SaMD) software as a medical device market.
Depending on application, the screening & diagnosis segment accounts for a high market share.
As per end user, the hospitals & clinics segment acquires a high stake in the market.
Region wise, North America is the highest revenue generator in the (SaMD) software as a medical device market.
Competition Analysis
The major players operating in the global (SaMD) software as a medical device market include MindMaze , Siemens, Biofourmis, BrightInsight, Inc., 4S Information Systems Ltd, Viz.ai, Inc., F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Orthogonal, and Zühlke Engineering AG. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Deployment Type
Cloud Based
On Premise
By Application
Screening and Diagnosis
Monitoring and Alerting
Chronic Disease Management
Digital Therapeutics
Others
By End User
Hospitals and Clinics
Home Care Settings
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
MindMaze
Siemens
Biofourmis
BrightInsight, Inc.
4S Information Systems Ltd,
Viz.ai, Inc.
F. Hoffmann-La Roche Ltd
Koninklijke Philips N.V.,
Orthogonal
Zühlke Engineering AG
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Deployment Type
- 4.2. Cloud Based
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. On Premise
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Screening And Diagnosis
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Monitoring And Alerting
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Chronic Disease Management
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Digital Therapeutics
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Others
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
- CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals And Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Home Care Settings
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Deployment Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Software as a Medical Device (SaMD) Market
- 7.2.6.1. Market Size and Forecast, By Deployment Type
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Software as a Medical Device (SaMD) Market
- 7.2.7.1. Market Size and Forecast, By Deployment Type
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Software as a Medical Device (SaMD) Market
- 7.2.8.1. Market Size and Forecast, By Deployment Type
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Deployment Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Software as a Medical Device (SaMD) Market
- 7.3.6.1. Market Size and Forecast, By Deployment Type
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Software as a Medical Device (SaMD) Market
- 7.3.7.1. Market Size and Forecast, By Deployment Type
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Software as a Medical Device (SaMD) Market
- 7.3.8.1. Market Size and Forecast, By Deployment Type
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Software as a Medical Device (SaMD) Market
- 7.3.9.1. Market Size and Forecast, By Deployment Type
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Software as a Medical Device (SaMD) Market
- 7.3.10.1. Market Size and Forecast, By Deployment Type
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Software as a Medical Device (SaMD) Market
- 7.3.11.1. Market Size and Forecast, By Deployment Type
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Deployment Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Software as a Medical Device (SaMD) Market
- 7.4.6.1. Market Size and Forecast, By Deployment Type
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Software as a Medical Device (SaMD) Market
- 7.4.7.1. Market Size and Forecast, By Deployment Type
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Software as a Medical Device (SaMD) Market
- 7.4.8.1. Market Size and Forecast, By Deployment Type
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Software as a Medical Device (SaMD) Market
- 7.4.9.1. Market Size and Forecast, By Deployment Type
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Software as a Medical Device (SaMD) Market
- 7.4.10.1. Market Size and Forecast, By Deployment Type
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
- 7.4.11.1. Market Size and Forecast, By Deployment Type
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Deployment Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Software as a Medical Device (SaMD) Market
- 7.5.6.1. Market Size and Forecast, By Deployment Type
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
- 7.5.7.1. Market Size and Forecast, By Deployment Type
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Software as a Medical Device (SaMD) Market
- 7.5.8.1. Market Size and Forecast, By Deployment Type
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
- 7.5.9.1. Market Size and Forecast, By Deployment Type
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. MindMaze
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Siemens
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Biofourmis
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. BrightInsight, Inc.
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. 4S Information Systems Ltd,
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Viz.ai, Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. F. Hoffmann-La Roche Ltd
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Koninklijke Philips N.V.,
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Orthogonal
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Zühlke Engineering AG
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 2. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CLOUD BASED, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 3. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR ON PREMISE, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 4. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 5. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR SCREENING AND DIAGNOSIS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 6. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR MONITORING AND ALERTING, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 7. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CHRONIC DISEASE MANAGEMENT, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 8. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR DIGITAL THERAPEUTICS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 9. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 10. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 11. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 12. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 13. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 14. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION, 2024 - 2033 ($MILLION)
- TABLE 15. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 16. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 17. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 18. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 19. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 20. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 21. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 22. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 23. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 24. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 25. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 26. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 27. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 28. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 29. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 30. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 31. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 32. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 33. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 34. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 35. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 36. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 37. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 38. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 39. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 40. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 41. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 42. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 43. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 44. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 45. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 46. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 47. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 48. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 49. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 50. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 51. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 52. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 53. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 54. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 55. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 56. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 57. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 58. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 59. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 60. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 61. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 62. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 63. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 64. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 65. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 66. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 67. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 68. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 70. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 72. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
- TABLE 73. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 74. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 75. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 76. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 77. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 78. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 79. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 80. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 81. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 82. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 83. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 84. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 85. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
- TABLE 86. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
- TABLE 87. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
- TABLE 88. MINDMAZE : KEY EXECUTIVES
- TABLE 89. MINDMAZE : COMPANY SNAPSHOT
- TABLE 90. MINDMAZE : OPERATING SEGMENTS
- TABLE 91. MINDMAZE : PRODUCT PORTFOLIO
- TABLE 92. MINDMAZE : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 93. SIEMENS: KEY EXECUTIVES
- TABLE 94. SIEMENS: COMPANY SNAPSHOT
- TABLE 95. SIEMENS: OPERATING SEGMENTS
- TABLE 96. SIEMENS: PRODUCT PORTFOLIO
- TABLE 97. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 98. BIOFOURMIS: KEY EXECUTIVES
- TABLE 99. BIOFOURMIS: COMPANY SNAPSHOT
- TABLE 100. BIOFOURMIS: OPERATING SEGMENTS
- TABLE 101. BIOFOURMIS: PRODUCT PORTFOLIO
- TABLE 102. BIOFOURMIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 103. BRIGHTINSIGHT, INC. : KEY EXECUTIVES
- TABLE 104. BRIGHTINSIGHT, INC. : COMPANY SNAPSHOT
- TABLE 105. BRIGHTINSIGHT, INC. : OPERATING SEGMENTS
- TABLE 106. BRIGHTINSIGHT, INC. : PRODUCT PORTFOLIO
- TABLE 107. BRIGHTINSIGHT, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 108. 4S INFORMATION SYSTEMS LTD, : KEY EXECUTIVES
- TABLE 109. 4S INFORMATION SYSTEMS LTD, : COMPANY SNAPSHOT
- TABLE 110. 4S INFORMATION SYSTEMS LTD, : OPERATING SEGMENTS
- TABLE 111. 4S INFORMATION SYSTEMS LTD, : PRODUCT PORTFOLIO
- TABLE 112. 4S INFORMATION SYSTEMS LTD, : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 113. VIZ.AI, INC. : KEY EXECUTIVES
- TABLE 114. VIZ.AI, INC. : COMPANY SNAPSHOT
- TABLE 115. VIZ.AI, INC. : OPERATING SEGMENTS
- TABLE 116. VIZ.AI, INC. : PRODUCT PORTFOLIO
- TABLE 117. VIZ.AI, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 118. F. HOFFMANN-LA ROCHE LTD : KEY EXECUTIVES
- TABLE 119. F. HOFFMANN-LA ROCHE LTD : COMPANY SNAPSHOT
- TABLE 120. F. HOFFMANN-LA ROCHE LTD : OPERATING SEGMENTS
- TABLE 121. F. HOFFMANN-LA ROCHE LTD : PRODUCT PORTFOLIO
- TABLE 122. F. HOFFMANN-LA ROCHE LTD : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 123. KONINKLIJKE PHILIPS N.V., : KEY EXECUTIVES
- TABLE 124. KONINKLIJKE PHILIPS N.V., : COMPANY SNAPSHOT
- TABLE 125. KONINKLIJKE PHILIPS N.V., : OPERATING SEGMENTS
- TABLE 126. KONINKLIJKE PHILIPS N.V., : PRODUCT PORTFOLIO
- TABLE 127. KONINKLIJKE PHILIPS N.V., : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 128. ORTHOGONAL: KEY EXECUTIVES
- TABLE 129. ORTHOGONAL: COMPANY SNAPSHOT
- TABLE 130. ORTHOGONAL: OPERATING SEGMENTS
- TABLE 131. ORTHOGONAL: PRODUCT PORTFOLIO
- TABLE 132. ORTHOGONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 133. ZüHLKE ENGINEERING AG: KEY EXECUTIVES
- TABLE 134. ZüHLKE ENGINEERING AG: COMPANY SNAPSHOT
- TABLE 135. ZüHLKE ENGINEERING AG: OPERATING SEGMENTS
- TABLE 136. ZüHLKE ENGINEERING AG: PRODUCT PORTFOLIO
- TABLE 137. ZüHLKE ENGINEERING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
- FIGURE 10. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY DEPLOYMENT TYPE
- FIGURE 11. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CLOUD BASED, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 12. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR ON PREMISE, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 13. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY APPLICATION
- FIGURE 14. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR SCREENING AND DIAGNOSIS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 15. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR MONITORING AND ALERTING, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 16. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 17. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR DIGITAL THERAPEUTICS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 18. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 19. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY END USER
- FIGURE 20. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 21. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 22. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
- FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 27. COMPETITIVE DASHBOARD
- FIGURE 28. COMPETITIVE HEATMAP: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
- FIGURE 29. TOP PLAYER POSITIONING, 2023
- FIGURE 30. MINDMAZE : NET SALES, 2021-2023 ($MILLION)
- FIGURE 31. MINDMAZE : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. MINDMAZE : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. SIEMENS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 34. SIEMENS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. SIEMENS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. BIOFOURMIS: NET SALES, 2021-2023 ($MILLION)
- FIGURE 37. BIOFOURMIS: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. BIOFOURMIS: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. BRIGHTINSIGHT, INC. : NET SALES, 2021-2023 ($MILLION)
- FIGURE 40. BRIGHTINSIGHT, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. BRIGHTINSIGHT, INC. : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. 4S INFORMATION SYSTEMS LTD, : NET SALES, 2021-2023 ($MILLION)
- FIGURE 43. 4S INFORMATION SYSTEMS LTD, : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. 4S INFORMATION SYSTEMS LTD, : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. VIZ.AI, INC. : NET SALES, 2021-2023 ($MILLION)
- FIGURE 46. VIZ.AI, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. VIZ.AI, INC. : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. F. HOFFMANN-LA ROCHE LTD : NET SALES, 2021-2023 ($MILLION)
- FIGURE 49. F. HOFFMANN-LA ROCHE LTD : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. F. HOFFMANN-LA ROCHE LTD : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 51. KONINKLIJKE PHILIPS N.V., : NET SALES, 2021-2023 ($MILLION)
- FIGURE 52. KONINKLIJKE PHILIPS N.V., : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 53. KONINKLIJKE PHILIPS N.V., : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 54. ORTHOGONAL: NET SALES, 2021-2023 ($MILLION)
- FIGURE 55. ORTHOGONAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 56. ORTHOGONAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 57. ZüHLKE ENGINEERING AG: NET SALES, 2021-2023 ($MILLION)
- FIGURE 58. ZüHLKE ENGINEERING AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 59. ZüHLKE ENGINEERING AG: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook